Chest, Vol 100, 910-916, Copyright © 1991 by American College of Chest Physicians

ARTICLES

Increased expression of leukocyte function associated antigen-1 (LFA-1) and intercellular adhesion molecule-1 (ICAM-1) by alveolar macrophages of patients with pulmonary sarcoidosis

M Melis, M Gjomarkaj, E Pace, G Malizia and M Spatafora
Consiglio Nazionale delle Ricerche Istituto di Fisiopatologia Respiratoria, Palermo, Italy.

Leukocyte function associated antigen-1 (LFA-1) and its ligand intercellular adhesion molecule-1 (ICAM-1) are cell adhesion molecules that play an important role in the capacity of monoculear phagocytes (MPs) to present antigens to T lymphocytes. Since in pulmonary sarcoidosis (PS) this capacity is increased at sites of disease activity, we studied the expression of LFA-1 and ICAM-1 on peripheral blood monocytes (BMs) and alveolar macrophages (AM) obtained by bronchoalveolar lavage (BAL) from normal subjects (n = 7) and patients with PS (n = 14). To accomplish this, immunocytochemical stainings were made on cytocentrifuge preparations using anti-LFA-1 (anti-CD 11a) and anti-ICAM-1 (anti-CD 54) monoclonal antibodies (MoAbs). Normal and sarcoid BMs displayed a high percentage of positivity with both MoAbs with no difference between study groups (LFA-1: control BM 87.8 +/- 8.8 percent; sarcoid BM 84.7 +/- 9.5 percent; ICAM-1: control BM 80.8 +/- 10 percent; sarcoid BM 88.0 +/- 4.2 percent; p = NS for all comparisons). In both groups the percentage of cells expressing LFA-1 and ICAM-1 molecules among AMs was lower than among autologous BMs (LFA- 1: control AM 46.5 +/- 13.2 percent, p less than 0.001 vs control BM; sarcoid AM 64.2 +/- 15.9; p less than 0.001 vs sarcoid BM) (ICAM-1: control AM 42.7 +/- 8.5 percent, p less than 0.001 vs control BM; sarcoid AM 72.1 +/- 10.6, p less than 0.001 vs sarcoid BM). AMs from patients with PS showed a higher degree of positivity for LFA-1 and ICAM-1 than normal AMs (p less than 0.02 and p less than 0.001, respectively). The positivity for LFA-1 and ICAM-1 molecules on sarcoid AMs was not correlated with the positivity for two different BM- associated markers (ie, the CD 11b and the CD 14 molecules) and was not correlated with the percentage of T lymphocytes in BAL, selected as a marker of the intensity of the alveolitis. These results suggest that the increased ability of sarcoid AMs to induce the proliferation of T lymphocytes may be related, at least in part, to the increased expression of LFA-1 and ICAM-1 molecules on their surfaces.

This article has been cited by other articles:

				D. S. Kim, S. H. Paik, C. M. Lim, S. D. Lee, Y. Koh, W. S. Kim, and W. D. Kim Value of ICAM-1 Expression and Soluble ICAM-1 Level as a Marker of Activity in Sarcoidosis Chest, April 1, 1999; 115(4): 1059 - 1065. [Abstract] [Full Text] [PDF]

				J Wahlström, M Berlin, C M Sköld, H Wigzell, A Eklund, and J Grunewald Phenotypic analysis of lymphocytes and monocytes/macrophages in peripheral blood and bronchoalveolar lavage fluid from patients with pulmonary sarcoidosis Thorax, April 1, 1999; 54(4): 339 - 346. [Abstract] [Full Text]

				M. Gjomarkaj, E. Pace, M. Melis, M. Spatafora, M. Profita, A. M. Vignola, G. Bonsignore, and G. B. Toews Phenotypic and Functional Characterization of Normal Rat Pleural Macrophages in Comparison with Autologous Peritoneal and Alveolar Macrophages Am. J. Respir. Cell Mol. Biol., January 1, 1999; 20(1): 135 - 142. [Abstract] [Full Text]

				M. TSUCHIDA, H. WATANABE, T. WATANABE, H. HIRAHARA, M. HAGA, H. OHZEKI, J. HAYASHI, H. MIYAMURA, T. HIRONO, T. ABO, et al. Effect of Cardiopulmonary Bypass on Cytokine Release and Adhesion Molecule Expression in Alveolar Macrophages . Preliminary Report In Six Cases Am. J. Respir. Crit. Care Med., September 1, 1997; 156(3): 932 - 938. [Abstract] [Full Text] [PDF]